The Centers for Medicare and Medicaid Services (CMS) has issued Healthcare Common Procedure Coding System (HCPCS) Level II Code K1007 for the ReWalk personal exoskeleton. The new code, which will be effective on October 1, 2020, is reportedly the first of its kind for exoskeletons, ReWalk Robotics Ltd reports.
HCPCS Level II codes are used to identify medical products and supplies and to facilitate insurance claim submissions and processing for these items. This code was announced in CMS’s First Biannual 2020 Durable Medical Equipment (DME) and Accessories; Orthotics, Prosthetics (O & P), and Supplies HCPCS code application review cycle update.
“We are committed to developing powered solutions for persons with lower limb disability as well as pursuing policies which make them available to those who may benefit from them. We are also proud to be pioneers in this industry. This successful coding application follows previous key company achievements such as earning the first FDA clearance for an exoskeleton, the first – and to date most – positive coverage decisions by U.S. private insurers for their beneficiaries, collaboration with the Department of Defense to establish a policy for injured US Veterans to have access to exoskeletons, and finalization of coverage policies and contracts with leading German insurers.”
— Andy Dolan, Vice President of Marketing and Reimbursement at ReWalk Robotics
The company intends to work with payors such as Medicare, state Medicaid and private insurers to establish an appropriate payment rate and pursue coverage policies for personal ownership of ReWalk devices. If and when these coverage policies are established, those who meet the inclusion criteria as established by the Food and Drug Agency (FDA) and complete the training program will have a pathway to seek a ReWalk Personal Exoskeleton for use at home, ReWalk Robotics continues, in the news release.
[Source(s): ReWalk Robotics Ltd, PR Newswire]
Related Content:
ReWalk Robotics Expands Rehab Product Portfolio
17th ReWalk 6.0 System Reimbursed By a Regional BCBS Plan
First Cigna Beneficiary to Receive ReWalk Exoskeleton
